Evrofarma SA Cash Flow-to-Debt Ratio
Evrofarma SA cash flow-to-debt ratio. Evrofarma SA (EVROF) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2022, meaning its operating cash flow of €1.52 Million could theoretically repay 0% of its total liabilities (€34.79 Million) in one year. Check EVROF operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Evrofarma SA (2014–2022)
Cash flow-to-debt ratio of Evrofarma SA from 2014 to 2022. Historical debt coverage capacity for Evrofarma SA across 9 annual periods. Check EVROF total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Evrofarma SA Cash Flow-to-Debt Ratio by Year (2014–2022)
Evrofarma SA cash flow-to-debt ratio by year from 2014 to 2022. Year-by-year debt coverage analysis for Evrofarma SA. For the full cash flow conversion analysis, see EVROF cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | 0.07x | €2.44 Million | €34.79 Million | ▲ +395.5% |
| 2021 | -0.02x | €-805.00K | €33.91 Million | ▼ -154.4% |
| 2020 | 0.04x | €1.46 Million | €33.42 Million | ▼ -28.0% |
| 2019 | 0.06x | €1.78 Million | €29.33 Million | ▼ -13.8% |
| 2018 | 0.07x | €2.29 Million | €32.58 Million | ▼ -22.2% |
| 2017 | 0.09x | €3.11 Million | €34.37 Million | ▲ +180.5% |
| 2016 | 0.03x | €1.08 Million | €33.55 Million | ▼ -19.9% |
| 2015 | 0.04x | €1.39 Million | €34.55 Million | ▲ +76.5% |
| 2014 | 0.02x | €866.00K | €38.00 Million | — |